AI-powered treatments for rare diseases
At Healx, we combine innovative AI technology, in-house drug discovery expertise and patient insight to accelerate the development of new and effective treatments for rare diseases.
This AI-powered approach enables us to discover, develop and take novel drugs to market faster, more cost-effectively and with a probability of success three times higher than traditional drug discovery methods allow. It has also enabled us to significantly scale our own portfolio to comprise a considerable number of projects across a range of rare disease areas – in a short space of time.
Together with partners, we work to take treatments all the way from in silico prediction and preclinical validation, through the clinic, and on to commercialisation via either the co-development or in-licensing of assets. Let’s collaborate to fast-track the development of novel and effective rare disease treatments.